8.	Concentrations

At June 30, 2014, we had four distributors that individually accounted for 16%, 16%, 14% and 10% of accounts receivable. At June 30, 2013, we had four distributors that individually accounted for 28%, 18%, 10% and 10% of accounts receivable.

Revenues from one distributor totaled $2,288 or 14%, $2,299 or 13% and $1,870 or 10% of net revenues for the years ended June 30, 2014, 2013 and 2012, respectively. Revenues from another distributor totaled $2,102 or 13% and $2,057 or 11% of net revenues for the years ended June 30, 2014 and 2013, respectively. Revenues from a customer totaled $1,849 or 12% for the year ended June 30, 2014.

The following represents our revenues by product platform for the years ended June 30:

	2014		2013		2012
AXP	$	6,143	$	7,687	$	7,814
BioArchive		4,776		4,258		4,310
Manual Disposables		1,706		2,286		2,200
Bone Marrow		2,542		2,390		2,076
Other		820		1,342		2,623
	$	15,987	$	17,963	$	19,023

We had sales to customers as follows for the years ended June 30:

	2014		2013		2012
United States	$	6,909	$	8,011	$	10,783
Hong Kong		2,321		2,006		514
China		848		2,058		609
Asia - other		1,864		1,855		2,887
Europe		3,072		2,030		1,806
South America		771		831		1,505
Other		202		1,172		919
	$	15,987	$	17,963	$	19,023

The Company has a contract manufacturer in Costa Rica that produces certain disposables. The Company provides AXP equipment to its distributor in China for use by end-user customers. The Company’s equipment, net of accumulated depreciation, is summarized below by geographic area:

	June 30, 2014		June 30, 2013
United States	$	687	$	1,005
China		620		678
Costa Rica		567		403
India		251		--
All other countries		173		122
Total equipment, net	$	2,298	$	2,208